Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Corgentech HIF Decoy Data Demonstrate Potent Tumor Inhibition in Preclinical Models
Apr 18, 2005
|
71.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., April 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) today announced that its Hypoxia-Inducible Factor Decoy (HIF Decoy) demonstrated substantial inhibition of tumor growth when tested in vivo in renal, colon and pancreatic tumor xenograft models as a monotherapy and had an additive effect...
|
|
|
Corgentech and Bristol-Myers Squibb Announce Results From Edifoligide (E2F Decoy) Phase 3 Trial for Coronary Artery Bypass Graft Failure
Mar 30, 2005
|
74.5 KB
|
| |
SOUTH SAN FRANCISCO, Calif. and PRINCETON, N.J., March 30, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), and Bristol-Myers Squibb Company (NYSE: BMY) today announced top-line results from PREVENT IV, a Phase 3 clinical trial evaluating the use of edifoligide (E2F Decoy), an investigational product, to prevent vein graft...
|
|
|
Corgentech to Host Webcast Conference Call on Wednesday, March 30, 2005
Mar 29, 2005
|
67.5 KB
|
| |
SOUTH SAN FRANCISCO, Calif., March 29, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) will host a webcast teleconference Wednesday, March 30, 2005 at 8:30 a.m. Eastern Time to review top-line results from PREVENT IV, a Phase 3 clinical trial testing edifoligide (E2F Decoy) for the treatment of coronary artery bypass graft...
|
|
|
Corgentech to Webcast Presentations From Three Upcoming Investor Conferences
Mar 24, 2005
|
67.3 KB
|
| |
SOUTH SAN FRANCISCO, Calif., March 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John P. McLaughlin, the company's president and chief executive officer, has been invited to present at three upcoming investor conferences. Each of the presentations will be webcast live an...
|
|
|
Corgentech Appoints Dorian Rinella Vice President of Human Resources
Mar 1, 2005
|
67.4 KB
|
| |
SOUTH SAN FRANCISCO, Calif., March 1, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) today announced that Dorian Rinella has been appointed vice president of human resources. Ms. Rinella joins Corgentech from Kosan Biosciences in Hayward, CA, where she served as vice president, human resources and facilities.
At Corg...
|
|
|
Click here to download our most recent fact sheet.